Report Detail
Global and China Biosimilars Market Insights, Forecast to 2026
- RnM4181314 |
- 01 September, 2020 |
- Global |
- 129 Pages |
- QYResearch |
- Pharma & Healthcare
Biosimilars market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Biosimilars market is segmented into
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Peptides (Glucagon, Calcitonin)
Segment by Application, the Biosimilars market is segmented into
Oncology
Blood Disorders
Regional and Country-level Analysis
The Biosimilars market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biosimilars market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilars Market Share Analysis
Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilars business, the date to enter into the Biosimilars market, Biosimilars product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Novartis
Teva Pharmaceuticals Industries
Amgen
Biocon
Dr. Reddy’s Laboratories
Roche Holding
Celltrion
Samsung BioLogics
1 Study Coverage
- 1.1 Biosimilars Product Introduction
- 1.2 Market Segments
- 1.3 Key Biosimilars Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Biosimilars Market Size Growth Rate by Type
- 1.4.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
- 1.4.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
- 1.4.4 Peptides (Glucagon, Calcitonin)
- 1.5 Market by Application
- 1.5.1 Global Biosimilars Market Size Growth Rate by Application
- 1.5.2 Oncology
- 1.5.3 Blood Disorders
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Biosimilars Market Size, Estimates and Forecasts
- 2.1.1 Global Biosimilars Revenue 2015-2026
- 2.1.2 Global Biosimilars Sales 2015-2026
- 2.2 Global Biosimilars, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Biosimilars Historical Market Size by Region (2015-2020)
- 2.3.1 Global Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Biosimilars Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Biosimilars Sales Forecast by Region (2021-2026)
- 2.4.2 Global Biosimilars Revenue Forecast by Region (2021-2026)
3 Global Biosimilars Competitor Landscape by Players
- 3.1 Global Top Biosimilars Sales by Manufacturers
- 3.1.1 Global Biosimilars Sales by Manufacturers (2015-2020)
- 3.1.2 Global Biosimilars Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Biosimilars Manufacturers by Revenue
- 3.2.1 Global Biosimilars Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Biosimilars Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Biosimilars Revenue in 2019
- 3.2.5 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Biosimilars Price by Manufacturers
- 3.4 Global Biosimilars Manufacturing Base Distribution, Product Types
- 3.4.1 Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Biosimilars Product Type
- 3.4.3 Date of International Manufacturers Enter into Biosimilars Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Biosimilars Market Size by Type (2015-2020)
- 4.1.1 Global Biosimilars Sales by Type (2015-2020)
- 4.1.2 Global Biosimilars Revenue by Type (2015-2020)
- 4.1.3 Biosimilars Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Biosimilars Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Biosimilars Sales Forecast by Type (2021-2026)
- 4.2.2 Global Biosimilars Revenue Forecast by Type (2021-2026)
- 4.2.3 Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Biosimilars Market Size by Application (2015-2020)
- 5.1.1 Global Biosimilars Sales by Application (2015-2020)
- 5.1.2 Global Biosimilars Revenue by Application (2015-2020)
- 5.1.3 Biosimilars Price by Application (2015-2020)
- 5.2 Biosimilars Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Biosimilars Sales Forecast by Application (2021-2026)
- 5.2.2 Global Biosimilars Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Biosimilars Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
- 6.1 China Biosimilars Market Size YoY Growth 2015-2026
- 6.1.1 China Biosimilars Sales YoY Growth 2015-2026
- 6.1.2 China Biosimilars Revenue YoY Growth 2015-2026
- 6.1.3 China Biosimilars Market Share in Global Market 2015-2026
- 6.2 China Biosimilars Market Size by Players (International and Local Players)
- 6.2.1 China Top Biosimilars Players by Sales (2015-2020)
- 6.2.2 China Top Biosimilars Players by Revenue (2015-2020)
- 6.3 China Biosimilars Historic Market Review by Type (2015-2020)
- 6.3.1 China Biosimilars Sales Market Share by Type (2015-2020)
- 6.3.2 China Biosimilars Revenue Market Share by Type (2015-2020)
- 6.3.3 China Biosimilars Price by Type (2015-2020)
- 6.4 China Biosimilars Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 China Biosimilars Sales Forecast by Type (2021-2026)
- 6.4.2 China Biosimilars Revenue Forecast by Type (2021-2026)
- 6.4.3 China Biosimilars Price Forecast by Type (2021-2026)
- 6.5 China Biosimilars Historic Market Review by Application (2015-2020)
- 6.5.1 China Biosimilars Sales Market Share by Application (2015-2020)
- 6.5.2 China Biosimilars Revenue Market Share by Application (2015-2020)
- 6.5.3 China Biosimilars Price by Application (2015-2020)
- 6.6 China Biosimilars Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 China Biosimilars Sales Forecast by Application (2021-2026)
- 6.6.2 China Biosimilars Revenue Forecast by Application (2021-2026)
- 6.6.3 China Biosimilars Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Biosimilars Market Size YoY Growth 2015-2026
- 7.2 North America Biosimilars Market Facts & Figures by Country
- 7.2.1 North America Biosimilars Sales by Country (2015-2020)
- 7.2.2 North America Biosimilars Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Biosimilars Market Size YoY Growth 2015-2026
- 8.2 Europe Biosimilars Market Facts & Figures by Country
- 8.2.1 Europe Biosimilars Sales by Country
- 8.2.2 Europe Biosimilars Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Biosimilars Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Biosimilars Market Facts & Figures by Country
- 9.2.1 Asia Pacific Biosimilars Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Biosimilars Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Biosimilars Market Size YoY Growth 2015-2026
- 10.2 Latin America Biosimilars Market Facts & Figures by Country
- 10.2.1 Latin America Biosimilars Sales by Country
- 10.2.2 Latin America Biosimilars Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Biosimilars Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Biosimilars Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Biosimilars Sales by Country
- 11.2.2 Middle East and Africa Biosimilars Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Pfizer
- 12.1.1 Pfizer Corporation Information
- 12.1.2 Pfizer Description and Business Overview
- 12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Pfizer Biosimilars Products Offered
- 12.1.5 Pfizer Recent Development
- 12.2 Novartis
- 12.2.1 Novartis Corporation Information
- 12.2.2 Novartis Description and Business Overview
- 12.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Novartis Biosimilars Products Offered
- 12.2.5 Novartis Recent Development
- 12.3 Teva Pharmaceuticals Industries
- 12.3.1 Teva Pharmaceuticals Industries Corporation Information
- 12.3.2 Teva Pharmaceuticals Industries Description and Business Overview
- 12.3.3 Teva Pharmaceuticals Industries Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Teva Pharmaceuticals Industries Biosimilars Products Offered
- 12.3.5 Teva Pharmaceuticals Industries Recent Development
- 12.4 Amgen
- 12.4.1 Amgen Corporation Information
- 12.4.2 Amgen Description and Business Overview
- 12.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Amgen Biosimilars Products Offered
- 12.4.5 Amgen Recent Development
- 12.5 Biocon
- 12.5.1 Biocon Corporation Information
- 12.5.2 Biocon Description and Business Overview
- 12.5.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Biocon Biosimilars Products Offered
- 12.5.5 Biocon Recent Development
- 12.6 Dr. Reddy’s Laboratories
- 12.6.1 Dr. Reddy’s Laboratories Corporation Information
- 12.6.2 Dr. Reddy’s Laboratories Description and Business Overview
- 12.6.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Dr. Reddy’s Laboratories Biosimilars Products Offered
- 12.6.5 Dr. Reddy’s Laboratories Recent Development
- 12.7 Roche Holding
- 12.7.1 Roche Holding Corporation Information
- 12.7.2 Roche Holding Description and Business Overview
- 12.7.3 Roche Holding Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Roche Holding Biosimilars Products Offered
- 12.7.5 Roche Holding Recent Development
- 12.8 Celltrion
- 12.8.1 Celltrion Corporation Information
- 12.8.2 Celltrion Description and Business Overview
- 12.8.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Celltrion Biosimilars Products Offered
- 12.8.5 Celltrion Recent Development
- 12.9 Samsung BioLogics
- 12.9.1 Samsung BioLogics Corporation Information
- 12.9.2 Samsung BioLogics Description and Business Overview
- 12.9.3 Samsung BioLogics Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Samsung BioLogics Biosimilars Products Offered
- 12.9.5 Samsung BioLogics Recent Development
- 12.11 Pfizer
- 12.11.1 Pfizer Corporation Information
- 12.11.2 Pfizer Description and Business Overview
- 12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Pfizer Biosimilars Products Offered
- 12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Biosimilars Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Biosimilars Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Biosimilars. Industry analysis & Market Report on Biosimilars is a syndicated market report, published as Global and China Biosimilars Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
